Rockville, MD, United States of America

Jiaqi Huang

This inventor holds 11 USPTO granted patents and 13 published patent applications and 1 EPO patent. Top assignees: Abelzeta Inc., Cellular Biomedicine Group Hk Limited, Cellular Biomedicine Group (Shanghai) Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiaqi Huang. Retrieved from https://idiyas.com/inventor/jiaqi-huang-gtemdguj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 36.4

 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations by Jiaqi Huang

Introduction

Jiaqi Huang is an accomplished inventor based in Rockville, MD, known for his significant contributions to the field of biotechnology. With a total of two patents to his name, he has made strides in developing innovative methods and reagents that enhance detection techniques in clinical settings.

Latest Patents

One of Jiaqi Huang's latest patents is titled "Reagent and method for fluorescence quantitative real-time PCR detection of RCL." This invention provides a reagent and method for detecting a replication-competent lentivirus (RCL) using fluorescence quantitative real-time polymerase chain reaction (PCR). The invention includes a primer and probe combination that allows for high amplification efficiency and specificity in detecting RCL, which is crucial for monitoring clinical patient peripheral blood samples during production processes.

Another notable patent is "Bispecific chimeric antigen receptors targeting CD20 and BCMA." This patent describes bispecific chimeric antigen receptors that can target both CD20 and BCMA. The CAR comprises an scFv targeting CD20 and an scFv targeting BCMA, along with a hinge region, a transmembrane domain, a co-stimulatory region, and a cytoplasmic signaling domain. These chimeric antigen receptors have potential applications in treating autoimmune disorders and cancer.

Career Highlights

Jiaqi Huang is currently employed at Abelzeta Inc., where he continues to work on innovative solutions in biotechnology. His expertise in developing advanced detection methods and therapeutic approaches has positioned him as a valuable asset in his field.

Collaborations

Jiaqi collaborates with talented individuals such as Yihong Yao and Shigui Zhu, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Jiaqi Huang's contributions to biotechnology through his patents and work at Abelzeta Inc. highlight his role as a leading inventor in the field. His innovative approaches to detection and treatment methods are paving the way for advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…